Standalone financial statement of Syn2bio for H1 FY2025 (01.10.2025-31.03.2026) / Polish
30.06.2026
See also
Syn2bio publishes its first periodic report
- Investor relations
- Press releases
The division of Synektik is complete – the court has registeredthe issue of Syn2bio shares
- Corporate news
- Investor relations
Synektik plans to devide. It is spinning off the cardiotracer research project into a new company which will also be listed on the WSE
- Corporate news
- Investor relations